Journal Logo

April 10th, 2005 - Volume 27 - Issue 7
pp: 3-96




When Compounds Are Promising But ‘Underdeveloped’, Who Picks up the Tab for Clinical Testing?

Fromer, Margot J.

Oncology Times. 27(7):40-44, April 10th, 2005.

In the world of new compounds that may or may not come to therapeutic fruition after initial optimism in the lab, who is responsible for what? Who owns the agent, who pays for the long and expensive years of testing, who reaps the financial benefits?










Show: